Overcome challenges and secure successful technology transfers of complex biological products in sterile manufacturing
Lonza launches GS Effex cell line to develop therapeutic antibodies with increased potency
Lonza expands PyroCell pyrogen testing portfolio with two new rapid systems
Swiss biomanufacturing sector continues to thrive in 2023
De-risk early stage drug development with Lonza Small Molecules
Accelerating early stage small molecule drug development
How to get a competitive edge in pharmaceutical development
Addressing challenges with clinical in-use testing of biotherapeutics
Advanced spray drying techniques for the formulation of poorly soluble compounds
Lonza upgrades module for enhanced electronic batch execution
Lonza and Vertex open transformative cell therapy facility
Lonza launches media system to aid therapeutic protein manufacture
Lonza to acquire Synaffix and strengthen ADCs offering
Lonza completes drug product manufacturing line
Advancing respiratory health through innovation
Lonza's powder upgrade in Tampa, US
